These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2529759)

  • 1. Evaluation of menogaril in patients with metastatic sarcomas and no prior chemotherapy exposure.
    Buckner JC; Edmonson JH; Ingle JN; Schaid DJ
    Am J Clin Oncol; 1989 Oct; 12(5):384-6. PubMed ID: 2529759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II evaluation of menogaril in women with metastatic breast cancer after failure of first-line chemotherapy.
    Long HJ; Schaid DJ; Schutt AJ; Ingle JN; Loprinzi CL; Edmonson JH
    Am J Clin Oncol; 1988 Oct; 11(5):524-7. PubMed ID: 2972192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of intravenous menogaril in patients with advanced breast cancer.
    Sessa C; Gundersen S; ten Bokkel Huinink W; Renard J; Cavalli F
    J Natl Cancer Inst; 1988 Sep; 80(13):1066-9. PubMed ID: 2970554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I study of menogaril in patients with advanced cancer.
    Brown TD; Donehower RC; Grochow LB; Rice AP; Ettinger DS
    J Clin Oncol; 1987 Jan; 5(1):92-9. PubMed ID: 2949065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I clinical investigation of 7-con-O-methylnogaril, a new anthracycline antibiotic.
    Dorr FA; Von Hoff DD; Kuhn JG; Schwartz R; Kisner DL
    Cancer Res; 1986 May; 46(5):2562-5. PubMed ID: 2938729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of menogaril in advanced colorectal cancer.
    Holdener EE; ten Bokkel Huinink WW; Decoster G; Ludwig C; Renard G; Pinedo HM
    Invest New Drugs; 1988 Sep; 6(3):227-30. PubMed ID: 2973448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I and pharmacokinetic study of menogaril administered as a 72-hour continuous i.v. infusion.
    Long HJ; Powis G; Schutt AJ; Moertel CG
    Cancer Treat Rep; 1987 Jun; 71(6):593-8. PubMed ID: 2953414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.
    Sigman LM; Van Echo DA; Egorin MJ; Whitacre MY; Aisner J
    Cancer Treat Rep; 1986 Jun; 70(6):721-5. PubMed ID: 2942244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive days.
    Dodion P; de Valeriola D; Crespeigne N; Peeters B; Wery F; van Berchem C; Piccart M; Tueni E; Joggi J; Kenis Y
    Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1019-26. PubMed ID: 2970391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of oral menogaril administered on a once weekly schedule.
    Stewart DJ; Verma S; Maroun JA; Robillard L; Earhart RH
    Invest New Drugs; 1990 Feb; 8(1):43-52. PubMed ID: 2140564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I clinical trial of oral menogaril administered on three consecutive days.
    Dodion P; de Valeriola D; Crespeigne N; Peeters B; Wery F; van Berchem C; Joggi J; Kenis Y
    Acta Oncol; 1988; 27(5):517-20. PubMed ID: 2974291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic.
    Long HJ; Laurie JA; Wieand HS; Edmonson JH; Levitt R; Krook JE; Abu-Ghazaleh S
    Cancer; 1991 Aug; 68(4):730-2. PubMed ID: 1830238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of menogaril in renal cell carcinoma. A Southwest Oncology Group phase II study (8504).
    Stephens RL; Goodman P; Crawford ED; Spicer CF; Lowe BA; Ahmann FR; Chapman R; Natale RB
    Invest New Drugs; 1990; 8 Suppl 1():S69-71. PubMed ID: 2143177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial.
    Gundersen S; Monfardini S; Renard G; Van Glabbeke M; Pinedo H
    Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1707-8. PubMed ID: 2962875
    [No Abstract]   [Full Text] [Related]  

  • 15. Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung.
    Joss RA; Monfardini S; Hansen M; Dombernowsky P; Renard J; Pinedo HM
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):263-5. PubMed ID: 2833403
    [No Abstract]   [Full Text] [Related]  

  • 16. Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study.
    Ettinger DS; Finkelstein DM; Abeloff MD; Skeel RT; Stott PB; Frontiera MS; Bonomi PD
    J Natl Cancer Inst; 1992 Jul; 84(14):1077-84. PubMed ID: 1320131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.
    Sessa C; Kaye SB; Renard J; ten Bokkel Huinink W; Cavalli F
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):751-2. PubMed ID: 2523809
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I study of intravenous menogaril administered intermittently.
    Dodion P; Sessa C; Joss R; Crespeigne N; Willems Y; Kitt M; Abrams J; Finet C; Brewer JE; Adams WJ
    J Clin Oncol; 1986 May; 4(5):767-74. PubMed ID: 2939203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction.
    Egorin MJ; Conley BA; Forrest A; Zuhowski EG; Sinibaldi V; Van Echo DA
    Cancer Res; 1987 Nov; 47(22):6104-10. PubMed ID: 2959359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of oral menogaril administered daily for 14 consecutive days.
    Stewart DJ; Aitken SE; Verma S; Maroun JA; Robillard L; Touchie M; Prosser IA; Earhart R
    Ann Oncol; 1992 May; 3(5):401-3. PubMed ID: 1535508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.